eccogene glp 1

eccogene glp 1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases AstraZeneca stays in GLP-1 drug

Name: eccogene glp 1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases AstraZeneca stays in GLP-1 drug
Brand: coasta-de-azur.fr
SKU: 44220545970
Price: 27.68 USD
Availability: InStock
Rating: 4.0225 (24 reviews)

SKU: 44220545970

4.0

EUR27.68 EUR62.68

Pay in 4 interest-free payments of $6.92 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

Cannabidiol protects an in vitro model of the bloodbrain barrier from oxygenglucose deprivation via PPAR and 5HT1A receptors

eccogene glp 1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases AstraZeneca stays in GLP-1 drug

The health benefits of phenolic compounds are often attributed to their antioxidant, anticarcinogenic, antimutagenic, antimicrobial, anti-inflammatory, and various other biological properties